There are 198 papers on leukemia in aging research: 5 trials and 60 observational studies in people, 55 in animals, 9 in cells, 63 reviews.
23 new papers in 30 daysSee all 736 papers on leukemia
At a glance
Biological-age acceleration is linked with higher leukemia risk in UK Biobank, and clonal hematopoiesis is linked with higher risk in WTC-exposed responders. Reviews describe leukemia-associated systemic aging and link inflammation in aged bone marrow with leukemia. In mice, low-level irradiation increases leukemia risk, whereas Epitalon lowers it.
38 findings in 37 papers from 1985 to 2026, 5 of them since April 2026
“The latter reflected higher risks for prostate cancer (HR, 1.04; 95% CI: 0.98-1.10; P-trend = 0.005), lung cancer (HR, 1.07; 95% CI: 0.96-1.20; P-trend = 0.003), and leukemia (HR, 1.26; 95% CI: 1.02-1.57; P-trend = 0.003).”
- Human trial5
- Humans60
- Animals51
- Model organisms4
- Cells9
- In silico6
Interventions
4CAR-T cells
downin rodent1
1 study
CAR-T cells
downin rodent1
CAR-T cells inhibit leukemia in rodent.
Animals
SGLT2 inhibitors
no changein humans1HR 0.76
1 study
SGLT2 inhibitors
no changein humans1HR 0.76
SGLT2 inhibitors were not clearly linked with leukemia in humans (Patients with diabetes; compared with non-SGLT2 inhibitor use) (HR 0.76, 95% CI 0.57–1.01; RD −0.02%).
HumansPatients with diabetes; compared with non-SGLT2 inhibitor use
Plutonium
no changein humans1
1 study
Plutonium
no changein humans1
Plutonium was not clearly linked with leukemia in humans (internal alpha-particle exposure).
Humansinternal alpha-particle exposure
C-type retrovirus
upin mice1
1 study
C-type retrovirus
upin mice1
C-type retrovirus induces leukemia in mice (injected into C3H and ST/a mice).
Animalsinjected into C3H and ST/a mice
Effects
2CVD co-listing on cancer-related death certificates
upin humans1
1 study
CVD co-listing on cancer-related death certificates
upin humans1
Leukemia is linked with higher CVD co-listing on cancer-related death certificates in humans (PMR 2.174).
Humans
Systemic aging
upin reviews1
1 study
Systemic aging
upin reviews1
Leukemia increases systemic aging (leukemia).
Reviewleukemia
Upstream
3Bone marrow failure
upin mice1
1 study
Bone marrow failure
upin mice1
Bone marrow failure induces leukemia in mice (driven by somatic aberrations).
Animalsdriven by somatic aberrations
RIPK3
downin mice1
1 study
RIPK3
downin mice1
RIPK3 protects against leukemia in response to fractionated low doses of ionizing radiation.
Animalsin response to fractionated low doses of ionizing radiation
ALDH2ANDADH5
downin mice1
1 study
ALDH2ANDADH5
downin mice1
ALDH2ANDADH5 prevents leukemia in mice (shown by double knockout).
Animalsshown by double knockout
Associations
24Clonal hematopoiesis of indeterminate potential
upin humans4upin reviews1OR 5.73
5 studies
Clonal hematopoiesis of indeterminate potential
upin humans4upin reviews1OR 5.73
Clonal hematopoiesis of indeterminate potential is linked with a higher risk of leukemia in WTC-exposed responders with CH versus without CH (3.7% vs. 0.6%; OR = 5.73).
Humansin WTC-exposed responders with CH versus without CH
Clonal hematopoiesis of indeterminate potential is associated with leukemia in humans (shared genetic architecture, 15 novel loci) (15 novel loci).
Humansshared genetic architecture, 15 novel loci
Clonal hematopoiesis of indeterminate potential raises the risk of leukemia.
Review
Clonal hematopoiesis of indeterminate potential raises the risk of leukemia in humans (0.5-1.0% risk per year).
Review
Clonal hematopoiesis of indeterminate potential raises the risk of leukemia in humans.
Review
Inflammation
upin humans1upin reviews1
2 studies
Inflammation
upin humans1upin reviews1
Inflammation raises the risk of leukemia in humans after stress or with exposure to prolonged chronic inflammation.
Reviewafter stress or with exposure to prolonged chronic inflammation
Inflammation raises the risk of leukemia.
Reviewin the aged bone marrow microenvironment, in the context of age-related clonal hematopoiesisbone marrow
Living near superfund sites
upin humans1
1 study
Living near superfund sites
upin humans1
Living near superfund sites are linked with a higher risk of leukemia in humans (living near Superfund sites).
Humansliving near Superfund sites
Allergy
upin humans1
1 study
Allergy
upin humans1
Allergy is linked with a higher risk of leukemia in humans.
Humansn = 34,403
SLC44A1
upin humans1
1 study
SLC44A1
upin humans1
Leukemia is associated with SLC44A1 in leukemia patients.
Humansin leukemia patients
Choline use supports leukemia progression in mice
Communications biology
Immune-mediated inflammatory disease
upin humans1
1 study
Immune-mediated inflammatory disease
upin humans1
Immune-mediated inflammatory disease is associated with leukemia in IMID patients (ORadj 1.98).
Humansin IMID patients
Clonal architecture
upin humans1
1 study
Clonal architecture
upin humans1
clonal architecture is associated with leukemia in humans.
Review
Retroviral integrations
upin P. cinereus1
1 study
Retroviral integrations
upin P. cinereus1
retroviral integrations are associated with leukemia in P. cinereus (captive population).
Animalscaptive population
JMJD6/SRSF2 locus
mixedin humans1
1 study
JMJD6/SRSF2 locus
mixedin humans1
JMJD6/SRSF2 locus is associated with leukemia in humans (genome-wide association studies using continuous risk scores).
Humansgenome-wide association studies using continuous risk scoresn = 350,000
HSF1
upin animals1
1 study
HSF1
upin animals1
HSF1 raises the risk of leukemia in Dnmt3a and Nras mutant context.
Animalsin Dnmt3a and Nras mutant context
All 24Fewer
Trial sponsors
Company9 trialsPhase 3777 people
Company6 trialsPhase 3760 people
Company4 trialsPhase 3
Novartis Pharmaceuticals Corporation
Company3 trialsPhase 3466 people
Company2 trialsPhase 31,239 people
Company1 trialPhase 3817 people
Company1 trialPhase 3360 people
Company1 trialPhase 3244 people
Funding
40 grants since 2017National Cancer Institute$35.5MNational Institute on Aging$3.2MNational Institute for Occupational Safety and Health$1.5M
The role of adverse social-biological interactions in acute myeloid leukemia disparities
National Cancer InstituteNorthwestern University$661K2025–2030
Metformin to prevent chemotherapy-induced neurotoxicity among children with leukemia
National Cancer InstituteRutgers Biomedical and Health Sciences$601K2026–2031
DNA methylation epimutations in leukemia
National Cancer InstituteWashington University$643K2026–2031
Aging trajectories and outcomes of older adults with acute myeloid leukemia
National Cancer InstituteUniversity of Nebraska Medical Center$515K2023–2028
National Institute on AgingUniversity of Pennsylvania$243K2025–2030
European CommissionUniversity of Bergen€5.3M2026–2030
INK4a and ARF in NK-cell senescence and leukemia
FWF Austrian Science FundUniversity of Veterinary Medicine Vienna€454K2025–2029
The influence of proteostasis loss in aging hematopoietic stem cells on leukemia initiation
National Cancer InstituteUniversity of California, San Diego$364K2021–2026
National Cancer InstituteEmory University$67.1K2020–2026
National Institute on AgingThe Jackson Laboratory$510K2021–2027
How this record changed
Summary written from the findings.